Oncolytic viruses as anticancer agents – clinical progress and remaining challenges (2025) Elizabeth Appleton

Description

This therapeutics paper analyzes the use of oncolytic viruses in cancer treatment, highlighting their unique ability to selectively destroy cancer cells and stimulate antitumour immunity. It covers key milestones in clinical development, discusses the barriers restricting widespread clinical implementation, and proposes future research directions to achieve meaningful patient benefit.